The government will inoculate frontline workers in essential economic sectors and maybe even the general public, after government finds that high-risk groups are slow to register for the Covid-19 inoculation.
According to Code Blue, people who have already signed up on MySejahtera for vaccination, regardless of their risk levels for severe Covid-19 disease, may be able to get their shots as early as April or May.
This would be skipping the wait which was initially reserved for the elderly or those with comorbidities in Phase Two of the national rollout which starts in April.
Vaccine minister Khairy Jamaluddin said they would be taking a more “dynamic look” at Phase Two.
“We’ve been able to do this because the number of registrations are still quite low.
“So, while waiting for senior citizens and people with comorbidities to register, we have some buffer to play around with for some of these economic sectors,” he told the portal.
Khairy also confirmed that foreign workers would also receive early Covid-19 vaccination in Phase Two of the national inoculation programme.
He also revealed that the government is still awaiting more senior citizens or those with underlying health conditions to sign up for their shots.
“I’ve made the decision that we’re not going to wait for people to register under Phase Two. If it’s going to be slow, then we just move Phase Three up.
“There’s no point waiting for people as long as we get a constant stream of vaccines coming in. I’m hoping to negotiate with Pfizer to bring some forward into Quarter Two, then we just vaccinate whoever is registered already.”
Only 26.56% of the population aged 18 and above have registered on the MySejahtera app for Covid-19 vaccination as of March 23.
The portal revealed that only 1.68 million elderly people or those with comorbidities have signed up on MySejahtera for Covid-19 vaccination, which is only 26% per cent of the 6,442,512 people registered on the app for jabs as of March 23.
Khairy said about 15 to 16 million Covid-19 vaccine doses are expected to be delivered to Malaysia in the second quarter of the year, comprising of Pfizer-BioNTech, Sinovac, Sputnik V and the AstraZeneca-Oxford vaccine from COVAX.